a public good project by the
Synthesis
Company
of California

© 2026

Kun Chen | doi.page

0 works0 citations0 h-index

Kun Chen

Zhejiang Chinese Medical University(CN)Zigong First People's Hospital(CN)Zhejiang University(CN)

Publications by Year

Research Areas

Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Colorectal Cancer Screening and Detection, Global Cancer Incidence and Screening, Immune Cell Function and Interaction

Most-Cited Works

→ Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study(2009)1,182 cited
→ Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review(2017)314 cited
→ D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1(2022)225 cited
→ Integrated Multi-Omics Landscape of Liver Metastases(2022)99 cited
→ Reduction of SIRT1 epigenetically upregulates NALP1 expression and contributes to neuropathic pain induced by chemotherapeutic drug bortezomib(2018)50 cited
→ Significance of intratumoral infiltration of B cells in cancer immunotherapy: From a single cell perspective(2021)47 cited

→ Ginkgolide B Suppresses TLR4‐Mediated Inflammatory Response by Inhibiting the Phosphorylation of JAK2/STAT3 and p38 MAPK in High Glucose‐Treated HUVECs(2017)

39 cited

→ Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer(2018)37 cited

→ Suppression of TLR4 activation by resveratrol is associated with STAT3 and Akt inhibition in oxidized low-density lipoprotein-activated platelets(2018)36 cited

→ The association between drinking water source and colorectal cancer incidence in Jiashan County of China: a prospective cohort study(2005)33 cited